Stocks · News reference

Vivos Therapeutics shares are trading lower. The company announced the receipt of a new U.S. patent and the extension of an existing patent related to its CARE sleep apnea devices.

Aug 5, 2026, 12:47 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 25, 2026, 12:47 PMBenzinga Newsdesk
Vivos Therapeutics Announces 212% Rise YoY Over Most Recent Six-Week Period In Its New Obstructive Sleep Apnea Patient Referrals At Its Nevada Sleep & Airway Medicine Centers
Vivos Therapeutics, Inc. ("Vivos" or "the Company") (NASDAQ:VVOS), a leading medical device and healthcare services company focused on developing and commercializing innovative diagnostic and treatment
Read original at benzinga
VVOS
SEC EDGARAug 21, 2026, 9:30 PMSEC EDGAR
8-K filing — Vivos Therapeutics, Inc. (VVOS)
Filed: 2026-08-21 AccNo: 0001493152-26-039736 Size: 224 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgar
VVOS
BenzingaAug 21, 2026, 9:06 PMBenzinga Insights
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Picard Medical (AMEX:PMI) stock rose 40.2% to $4.5 during Friday's after-market session. The company's market cap stands at $6.2 million. As per the news, the Q2 earnings report came out 2 days ago.
Read original at benzinga
ADXN ALPS BCAB CDT ENLV
BenzingaAug 14, 2026, 10:37 PMBenzinga Insights
Vivos Therapeutics Reports Q2 2026 Results: Full Earnings Call Transcript
Vivos Therapeutics (NASDAQ:VVOS) held its second-quarter earnings conference call on Friday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data and
Read original at benzinga
VVOS